PTC Therapeutics | PTCT - 债务



金融业
股票价格
USD
资产
USD 3.25B
现金及等价物
USD 1.05B
销售成本
USD 39.61M
流动资产
USD 2.62B
流动负债
USD 771.07M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD 61.98M
员工
939
EPS每股收益
USD 0.92
股本和储备
USD -165.36M
销售毛利
USD 232.94M
债务利息支出
USD 3.25B
贷款资金
USD 535.52M
市值
USD 5.16B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 82.88M
PE价格收益
8.76
税前利润
USD -2.46M
销售收入
USD 361M
销售和管理费用
USD 73.89M
股票
USD 91.35M
贸易债权人
USD 40.45M
应收帐款人
USD 219.92M


债务 更改 日
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amgen USD 57.32B 2.72B 2026-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cytokinetics USD 1.29B 4.48M 2026-03
Daiichi Sankyo JPY 300.48B 99.34B 2026-03
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Gilead Sciences USD 22.17B 2.76B 2026-03
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
TG Therapeutics USD 754.44M 884K 2026-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06
Xencor USD 175.16M 12.58M 2026-03